ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

OLMA Olema Pharmaceuticals Inc

9,48
-0,35 (-3,56%)
27 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Olema Pharmaceuticals Inc OLMA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,35 -3,56% 9,48 01:00:09
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
9,87 9,51 10,09 9,95 9,83
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/04/202417:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
02/04/202417:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
11/03/202417:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
06/03/202409:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
04/03/202418:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
06/02/202409:01GLOBEOlema Oncology to Participate in Upcoming Investor..
02/02/202418:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
08/01/202410:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
02/01/202418:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
05/12/202314:27GLOBEOlema Oncology Announces Palazestrant Demonstrates..
04/12/202318:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
28/11/202319:10GLOBEOlema Oncology to Present New Palazestrant Clinical Data in..
07/11/202318:02GLOBEOlema Oncology Reports Third Quarter 2023 Financial Results..
02/11/202317:32GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/11/202317:27GLOBEOlema Oncology to Participate in Upcoming Investor..
22/10/202303:55GLOBEOlema Oncology Announces Positive Phase 2 Monotherapy..
17/10/202308:01GLOBEOlema Oncology Appoints Oncology Biotech Executive Scott..
16/10/202308:02GLOBEOlema Oncology Announces Phase 2 Monotherapy Clinical..
12/10/202308:01GLOBEOlema Oncology KAT6 Inhibitor Compounds Demonstrate Potent..
10/10/202308:00GLOBEOlema Oncology Announces Expansion of Collaboration..
03/10/202317:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
20/09/202308:29GLOBEOlema Oncology Announces New Preclinical KAT6 Inhibitor Data..
06/09/202317:30GLOBEOlema Oncology to Participate in Upcoming Investor..
05/09/202317:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
05/09/202308:30GLOBEOlema Oncology Announces Combined Financing for Up to $180..
08/08/202317:03GLOBEOlema Oncology Reports Second Quarter 2023 Financial Results..
02/08/202317:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/08/202309:00GLOBEOlema Oncology to Present at the Canaccord Genuity 43rd..
05/07/202308:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/06/202317:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
30/05/202317:30GLOBEOlema Oncology to Present at the 2023 Jefferies Healthcare..
11/05/202309:43GLOBEOlema Oncology Announces OP-1250 Continues to Demonstrate..
09/05/202317:01GLOBEOlema Oncology Reports First Quarter 2023 Financial Results..
08/05/202308:06GLOBEOlema Oncology Announces Upcoming Poster Presentation at the..
02/05/202317:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..

Seu Histórico Recente

Delayed Upgrade Clock